Advancing innovation with long-term lipid-lowering H.E.L.P.®
The Plasmat® Futura Apheresis System is B. Braun’s device for H.E.L.P.® (Heparin-induced Extracorporeal LDL Cholesterol Precipitation), LDL apheresis therapy that selectively removes low density lipoproteins for the treatment of severe cholesterolemia.
The Plasmat® Futura system offers help for those with few alternatives for treatment, patients with severe familial hypercholesterolemia whose cholesterol levels remain high despite the latest diet and drug therapy.
H.E.L.P.® therapy incorporates an innovative and effective blood cleansing procedure for the long-term management of patients with severe Familial Hypercholesterolemia.
The Plasmat® Futura system was designed for ease of use, mobility and flexibility, offering:
- A user-friendly interface
- Clearly displayed and easy-to-adjust treatment parameters
- Extracorporeal circuit diagram
- Fully automated priming, rinsing, and reinfusion operations
- User support with message prompts and warnings
|Latex Information||Not made with Natural Rubber Latex|
|Total Shelf Life (Months)||999|
Case Study - Unmasking Hypotension
LDL - Apheresis Lipidology
|pdf (305.0 KB)||open|
Placebo Retrospective analysis of long term lipid apheresis at a single center.
|pdf (238.8 KB)||open|
HELP Patient's Guide
|pdf (5.6 MB)||open|
HELP Physician's Brochure
|pdf (244.3 KB)||open|